Peng YIN, Ph.D

Chief Scientific Officer

Peng leads our global R&D strategy and drive the development of our PHASIFY™ platform into scalable, market-ready innovations.

Peng brings over 25 years of global experience in diagnostics and biotechnology, including senior leadership roles at Abbott Diagnostics and Sansure Biotech.

Peng holds a Ph.D. in Molecular Virology from the University of Manitoba and completed his postdoctoral fellowship at Harvard University. He is a Fellow of the National Academy of Clinical Biochemistry.